Associated Papers
Clinical significance of pharmacogenomic studies in tardive dyskinesia associated with patients with psychiatric disorders.
Chang FC et al.
Pharmacogenomics and Personalized Medicine, 2014
Bioinformatic analyses to select phenotype affecting polymorphisms in HTR2C gene.
Piva F et al.
Human Psychopharmacology, 2011
Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction.
Zhang JP et al.
Expert Opinion on Drug Metabolism & Toxicology, 2011
Association study of serotonergic gene variants with antipsychotic-induced adverse reactions.
Al-Janabi I et al.
Psychiatric Genetics, 2009
The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment: Curacao extrapyramidal syndromes study IX.
Wilffert B et al.
Journal of Psychopharmacology (oxford, England), 2009
Association of unipolar depression with gene polymorphisms in the serotonergic pathways in Han Chinese.
Shi M et al.
Acta Neuropsychiatrica, 2008
G protein-coupled receptor pharmacogenetics.
Thompson MD et al.
Methods in Molecular Biology (clifton, N.j.), 2008
Serotonergic candidate genes and puerperal psychosis: an association study.
Kumar HB et al.
Psychiatric Genetics, 2007
Depression in Alzheimer's disease: the effect of serotonin receptor gene variation.
Holmes C et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics, 2003
An investigation of the 5-HT2C receptor gene as a migraine candidate gene.
Johnson MP et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics, 2003
Association between a polymorphism of the 5-HT2C receptor and weight loss in teenage girls.
Westberg L et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, 2002
Novel 5'-regulatory region polymorphisms of the 5-HT2C receptor gene: association study with panic disorder.
Deckert J et al.
The International Journal of Neuropsychopharmacology, 2000
Identification of polymorphic loci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and type II diabetes.
Yuan X et al.
Diabetologia, 2000
5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease.
Holmes C et al.
Human Molecular Genetics, 1998
Allelic association analysis of the 5-HT2C receptor gene in bipolar affective disorder.
Gutiérrez B et al.
Neuroscience Letters, 1996